Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur J Pharmacol. 2008 May 13;585(2-3):453-7. doi: 10.1016/j.ejphar.2008.03.010. Epub 2008 Mar 18.

Pharmacological manipulation of memory reconsolidation: towards a novel treatment of pathogenic memories.

Author information

1
Department of Anatomy and Neurosciences, Center for Neurogenomics and Cognitive Research, VU Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. l.diergaarde@vumc.nl

Abstract

Well-consolidated memories, when retrieved, may return to a transiently fragile state, and need to be consolidated again in order to be maintained. This process has been referred to as memory reconsolidation and presumably serves to modify or strengthen memory traces. In recent years, our understanding of the neurobiological mechanisms underlying this phenomenon has increased rapidly. Here, we will briefly review some of the pharmacological evidence, stressing a crucial role for the brain's major neurotransmitter systems, such as glutamate and noradrenaline, in memory reconsolidation. Pharmacological intervention of reconsolidation processes may have clinical relevance, especially for the treatment of psychiatric disorders that are characterized by pathological memories, including post-traumatic stress disorder and addictive behaviour.

PMID:
18410917
DOI:
10.1016/j.ejphar.2008.03.010
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center